LMR Partners’s 2seventy bio TSVT Stock Holding History

LMR Partners’s Portfolio TSVT Stock Details TSVT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q2	–	Sell	-73,920	Closed	-$1.26M	–	1469
2022 Q1	$1.26M	Buy	73,920 +18,772	+34%	+$318K	0.01%	725
2021 Q4	$1.41M	Buy	+55,148	New	+$1.72M	0.01%	600

Other funds holding TSVT

EcoR1 Capital San Francisco, California $2.36B AUM 204.53% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BBA

Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return

MAP

Madison Avenue Partners New York $2.3B AUM 115.82% 1-Year Est. Return

BCLSI

Bain Capital Life Sciences Investors Boston, Massachusetts $1.11B AUM 171.34% 1-Year Est. Return

Newtyn Management New York $936M AUM 27.23% 1-Year Est. Return

RTW Investments New York $10B AUM 135.35% 1-Year Est. Return

LMR Partners's TSVT Position: Q2 2022 in Review

LMR Partners sold out of 2seventy bio (TSVT) in Q2 2022, closing a stake of 73,920 shares — an estimated $1.26M sold.

LMR Partners first reported a position in TSVT in Q4 2021 and held it in 2 quarters. The position peaked at $1.41M in Q4 2021. 132 funds tracked by Wall St. Rank hold TSVT as of Q2 2022.

LMR Partners reported no remaining 2seventy bio position as of Q2 2022 after selling out during the quarter.
LMR Partners sold 73,920 2seventy bio shares in Q2 2022, an estimated $1.26M.
LMR Partners first reported a position in 2seventy bio in Q4 2021 and held it in 2 quarters.
LMR Partners's 2seventy bio position peaked at $1.41M in Q4 2021.
132 funds tracked by Wall St. Rank held 2seventy bio as of Q2 2022.

Based on LMR Partners's 13F filing for Q2 2022, filed 15 Aug 2022.